Vext Science ( (VEXTF) ) has released its Q4 earnings. Here is a breakdown of the information Vext Science presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, specializing in cultivation, manufacturing, and retail of cannabis products, including the Vapen™ brand. The company is recognized for its state-of-the-art facilities and award-winning products, aiming to expand its market presence in its core states.
In its latest earnings report, Vext Science announced a strong performance in the fourth quarter of 2024, marking it as one of the most successful quarters in recent years. The company reported a 13% sequential increase in revenue, reaching $10.2 million, largely driven by the adult-use market in Ohio and steady operations in Arizona.
Key financial highlights include an adjusted EBITDA of $3.2 million in Q4 2024, a significant improvement from the previous year, and a positive cash flow from operations of $4 million. The company also secured approval for the acquisition of Big Perm dispensaries in Ohio, positioning itself to reach the state’s dispensary license cap by early 2026.
Looking ahead, Vext Science is focused on driving free cash flow, reducing debt, and maximizing shareholder value. With regulatory approval for its Ohio expansion and continued optimization in Arizona, the company is well-positioned to increase its market share and achieve long-term profitability.